Zobrazeno 1 - 10
of 36
pro vyhledávání: '"Jayashree, Motwani"'
Autor:
Jan Blatný, Jan Astermark, Cristina Catarino, Gerry Dolan, Karin Fijnvandraat, Cédric Hermans, Katharina Holstein, Víctor Jiménez-Yuste, Robert Klamroth, Michelle Lavin, Peter J. Lenting, Sébastien Lobet, Maria Elisa Mancuso, Jayashree Motwani, James S. O’Donnell, Christoph Königs
Publikováno v:
Therapeutic Advances in Hematology, Vol 15 (2024)
Over recent decades, management of people with hemophilia (PwH) has been greatly improved by scientific advances that have resulted in a rich and varied therapeutic landscape. Nevertheless, treatment limitations continue to drive innovation, and emer
Externí odkaz:
https://doaj.org/article/49b84b74635547b39a4cb8316ffbb30c
Autor:
Eman Hassan, Jayashree Motwani
Publikováno v:
Thrombosis Research. 221:92-96
Paediatric clinical practice for treatment of venous thromboembolism (VTE) is based on extrapolation from adult trials with minimal data on anticoagulation efficacy and safety in children. Based on EINSTEIN-Jr clinical trial data, rivaroxaban was app
Autor:
Richard, Gallon, Rachel, Phelps, Leigh, Betts, Christine, Hayes, Dino, Masic, Julie A E, Irving, Ciaron, McAnulty, Vaskar, Saha, Ajay, Vora, Katharina, Wimmer, Jayashree, Motwani, Christine, Macartney, John, Burn, Michael S, Jackson, Anthony V, Moorman, Mauro, Santibanez-Koref
Publikováno v:
Leukemia & Lymphoma. 64:217-220
Autor:
David E, Schmidt, Aikaterini, Michalopoulou, Kathelijn, Fischer, Jayashree, Motwani, Nadine G, Andersson, Helen, Pergantou, Susanna, Ranta
Publikováno v:
Haemophilia. 28:1054-1061
Favourable joint outcomes are expected with modern haemophilia A (HA) management. Evaluation of long-term treatment outcomes is hampered by the delay between bleeding episodes during childhood and resulting joint outcomes in adulthood.To measure the
Autor:
Angus Hodder, Avijeet K Mishra, Katherine Clesham, Susan Baird, Kaljit Bhuller, Ismail Bisho, Denise Bonney, Anna Castleton, Michelle Cummins, Emmy Dickens, Lindsay George, Sara Ghorashian, Brenda Gibson, Chris Hasley, Nicholas Heaney, Rachael E Hough, Danielle Ingham, Galina Jigoulina, Katherine Lindsay, Donna Lancaster, Majid Madni, Andrea Malone, Bethany Mitchell, Anthony V. Moorman, John Moppett, Vanessa McLelland, Jayashree Motwani, Emma Nicholson, Caroline Osborne, Katharine Patrick, Lamia Samrin, Sanjay Tewari, Indu Rakesh Thakur, Sujith Samarasinghe, Ajay Vora, David O'Connor
Publikováno v:
Blood. 140:3268-3270
Autor:
Eman Hassan, Jayashree Motwani
Publikováno v:
Pediatric Hematology and Oncology. 39:418-426
Emicizumab has been widely used for prophylaxis in patients with hemophilia A (HA) of all ages, with or without factor VIII inhibitors. Data on emicizumab efficacy are certainly significant; however, protection against bleeding is not absolute, and t
Autor:
Jayanthi Alamelu, Tina T. Biss, Mary Mathias, Georgina W. Hall, Oliver Tunstall, Neha Bhatnagar, Elizabeth Chalmers, Charles R. M. Hay, Jeanette Payne, Daniel P. Hart, Ben Palmer, Michael Makris, Charles Percy, Kate Talks, Peter William Collins, Anne Riddell, Michael Richards, Ri Liesner, Jayashree Motwani
Publikováno v:
Haemophilia. 27:932-937
INTRODUCTION In good risk patients (historic inhibitor peak
Publikováno v:
Journal of Blood Medicine
Joint health is a key contributor to quality of life in patients with hemophilia. However, variables that impact long-term joint outcomes have not been comprehensively defined. A systematic literature search identified publications relating to joint
Autor:
Susan Baird, Fanny Bajolle, Sebastian Grunt, Olga Lvova, Anthonie W. A. Lensing, Mayte Sánchez van Kammen, William T. Smith, Paolo Simioni, Madhurima Majumder, Christoph Male, Jeanette Payne, Tina T. Biss, Michelle Morales Soto, Veerle Labarque, Elizabeth Chalmers, Joseph Palumbo, Jonathan M. Coutinho, Damien Bonnet, Amparo Santamaría, Riten Kumar, An Van Damme, Ida Martinelli, Kamar Godder, Sanjay J. Shah, Paul Monagle, Paola Saracco, Dagmar Kubitza, Philip Connor, Martin H. Prins, Rukhmi Bhat, Krisztián Kállay, Akos F. Pap, Scott D. Berkowitz, Kerry Hege, Jayashree Motwani, Helene L. Hooimeijer
Publikováno v:
Blood advances, 4(24), 6250-6258. The American Society of Hematology
Blood Advances
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Blood advances, 4(24), 6250-6258. American Society of Hematology
Blood Adv.
Blood Adv
Blood Advances
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Blood advances, 4(24), 6250-6258. American Society of Hematology
Blood Adv.
Blood Adv
Anticoagulant treatment of pediatric cerebral venous thrombosis has not been evaluated in randomized trials. We evaluated the safety and efficacy of rivaroxaban and standard anticoagulants in the predefined subgroup of children with cerebral venous t
Autor:
Konrad Van Der Zwet, Marloes de Kovel, Jayashree Motwani, Christel Van Geet, Beatrice Nolan, Heidi Glosli, Gili Kenet, Kathelijn Fischer
Publikováno v:
Blood. 140:8442-8443